Register Now

The New Frontiers in Injectable Excellence

Injectables have quietly become the engine behind India’s next pharma growth story. Once a niche within formulations, they are now among the fastest-expanding segments, driven by demand for safer, faster and more effective therapies. According to IMARC Group, India’s generic injectables market is projected to reach $7.6 billion by 2033, growing at a CAGR of 10.28 per cent.

Yet this growth story comes with real challenges like heightened regulatory scrutiny from global agencies, heavy dependence on imported APIs, and capability gaps in areas such as biosimilars, oncology injectables and advanced formulations.

Express Pharma’s second edition of the Injectable Innovations Conclave 2026 is designed to be a catalyst for the next leap of growth in this segment. Under the theme, ‘The new frontiers in injectable excellence,’ it will bring together leaders from R&D, sterile operations, packaging, supply chain and technology, to strengthen India’s injectable ecosystem. It will enable and empower the players to compete on innovation, quality and reliability, not just scale.

To lead the next era of injectables, the industry must integrate sterility, science, packaging innovation, automation and quality into one powerful ecosystem. Join the Injectable Innovations Conclave 2026 and be a part of shaping this future

For more information visit the website: https://iic.expresspharma.in/